文献速递生殖医学

B细胞淋巴瘤6表达在接受冻融胚胎移植不同子宫内膜准备方案间存在显著差异

B-cell lymphoma 6 expression significantly differs by the uterine preparation method used for frozen embryo transfer.
PubMed 文献 · Fertil Steril · 2023-04-20

该回顾性队列研究纳入244例不孕患者,比较自然周期、改良自然周期及程序化周期下子宫内膜BCL6组织学评分及过表达率。结果显示外源性孕酮暴露组BCL6过表达率显著低于自然周期组,作者认为BCL6检测在药物准备子宫内膜状态下的有效性和实用性需进一步研究。

要点

  • 自然周期组BCL6过表达率80.3%,改良自然周期组40.0%,程序化周期组23.1%。
  • 外源性孕酮暴露组BCL6过表达风险显著低于自然周期组。
  • BCL6检测在药物准备子宫内膜状态下的有效性和实用性需进一步研究。

核心结论

  • BCL6表达因子宫内膜准备方法不同而异,外源性孕酮暴露时水平较低。
  • BCL6检测在药物准备子宫内膜状态下的有效性和实用性需进一步研究。

研究设计与样本

  • 回顾性队列研究,在学术中心进行,纳入244例因不孕接受子宫内膜活检以评估BCL6的患者。
  • 干预为外源性雌二醇和/或孕酮。
  • 主要结局指标为子宫内膜BCL6组织学评分(HSCORE)及过表达(HSCORE >1.4)。

主要发现

  • 76例在未暴露外源性激素的自然月经周期取样(NC),25例在改良自然周期方案(注射绒促性素α后黄体期阴道补充孕酮)取样(mNC),143例在程序化周期方案(给予雌二醇后加用肌内注射黄体酮油剂)取样(PC)。
  • HSCORE中位数(四分位距)在NC组最高,为3.0(1.8-3.6)。
  • BCL6表达在mNC组(1.1[0.4-2.1])和PC组(0.8[0.3-1.3])均显著低于NC组。
  • BCL6过表达(HSCORE >1.4)在NC组为80.3%,mNC组为40.0%,PC组为23.1%。
  • 校正协变量后,暴露于外源性孕酮的子宫内膜BCL6过表达的比值比显著低于自然月经周期:mNC组校正比值比为0.12(95%CI 0.04-0.35),PC组比值比为0.08(95%CI 0.04-0.17)。

关键数值与推荐

  • BCL6过表达定义为HSCORE >1.4。
  • HSCORE中位数(四分位距):NC组3.0(1.8-3.6),mNC组1.1(0.4-2.1),PC组0.8(0.3-1.3)。
  • BCL6过表达率:NC组80.3%,mNC组40.0%,PC组23.1%。
  • 校正后BCL6过表达比值比:mNC组0.12(95%CI 0.04-0.35),PC组0.08(95%CI 0.04-0.17),均以自然月经周期为参照。

临床怎么用

  • 作者认为BCL6检测在药物准备子宫内膜状态下的有效性和实用性需进一步研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether B-cell lymphoma 6 (BCL6), an endometriosis-associated marker postulated to predict poor pregnancy outcomes, is differentially expressed in the window of implantation with various uterine preparation regimens commonly used for frozen embryo transfers. DESIGN: A retrospective cohort study. SETTING: An academic center. PATIENT(S): Patients with infertility who underwent endometrial biopsy for BCL6 evaluation INTERVENTION(S): Exogenous estradiol and/or progesterone. MAIN OUTCOME MEASURE(S): Endometrial BCL6 histological score (HSCORE) and overexpression (HSCORE >1.4) RESULT(S): Two hundred and forty-four patients were included in the analysis: 76 patients were sampled in a natural menstrual cycle without exogenous hormone exposure (NC), 25 under a modified natural cycle embryo transfer protocol with choriogonadotropin alfa injection followed by luteal phase vaginal progesterone supplementation (mNC), and 143 under a programmed cycle embryo transfer protocol, with estradiol administration followed by addition of intramuscular progesterone-in-oil injections (PC). Median HSCORE (interquartile range) was the highest in NC (3.0 [1.8-3.6]). BCL6 expression was significantly lower in mNC (1.1 [0.4-2.1]) and PC groups (0.8 [0.3-1.3]) compared with NC. In addition, BCL6 overexpression (HSCORE >1.4) was observed in 80.3% of NC, 40.0 % of mNC, and 23.1 % of PC. After adjusting for covariates, the endometrium exposed to exogenous progesterone had significantly lower odds of BCL6 overexpression than that of a natural menstrual cycle (adjusted odds ratio, 0.12 [95% CI 0.04-0.35] for mNC; and odds ratio, 0.08 [95% CI 0.04-0.17] for PC). CONCLUSION(S): BCL6 expression differs by the type of uterine preparation method, with lower levels observed with exogenous progesterone exposure. The validity and utility of BCL6 testing under medicated endometrial state warrants further investigation.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Huang D, Chan M, Solomon M, et al. B-cell lymphoma 6 expression significantly differs by the uterine preparation method used for frozen embryo transfer. Fertil Steril. 2023. PMID: 37085097. doi:10.1016/j.fertnstert.2023.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。